June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Investigation of a novel rabbit nonpolar lipid for the treatment of evaporative dry eye disease in a murine model
Author Affiliations & Notes
  • Brian Leonard
    University of California Davis, Davis, California, United States
  • Erin Hisey
    University of California Davis, Davis, California, United States
  • Sangwan Park
    University of California Davis, Davis, California, United States
  • Daniel M Albert
    Oregon Health & Science University, Portland, Oregon, United States
    MCAL Therapeutics, Utah, United States
  • Charles O’Neill
    MCAL Therapeutics, Utah, United States
  • Christopher J Murphy
    MCAL Therapeutics, Utah, United States
  • Thomas R Gadek
    MCAL Therapeutics, Utah, United States
  • Jennifer Y Li
    University of California Davis, Davis, California, United States
  • Sara M Thomasy
    University of California Davis, Davis, California, United States
  • Atul N Parikh
    University of California Davis, Davis, California, United States
  • Footnotes
    Commercial Relationships   Brian Leonard MCAL Therapeutics, Code R (Recipient); Erin Hisey None; Sangwan Park None; Daniel Albert MCAL Therapeutics, Code O (Owner); Charles O’Neill MCAL Therapeutics, Code O (Owner); Christopher Murphy MCAL Therapeutics, Code O (Owner); Thomas Gadek MCAL Therapeutics, Code O (Owner); Jennifer Li None; Sara Thomasy None; Atul Parikh None
  • Footnotes
    Support  K08EY02819, University of California, Davis
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 712. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Brian Leonard, Erin Hisey, Sangwan Park, Daniel M Albert, Charles O’Neill, Christopher J Murphy, Thomas R Gadek, Jennifer Y Li, Sara M Thomasy, Atul N Parikh; Investigation of a novel rabbit nonpolar lipid for the treatment of evaporative dry eye disease in a murine model. Invest. Ophthalmol. Vis. Sci. 2023;64(8):712.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Evaporative dry eye disease (EDED) is a group of disorders characterized by abnormalities in the tear film, most commonly its lipids, that lead to instability and increased evaporation. We recently identified a novel nonpolar lipid (NPL) isolated from the Harderian gland of the rabbit (rNPL593), a species with an exceptionally stable tear film, not identified in the meibum or tears of any other species to date. This preliminary study sought to determine the clinical efficacy of a synthesized version of rNPL593 in a murine model of EDED.

Methods : A colony of mice deficient in an enzyme that synthesizes long chain wax esters, acyl-CoA: wax alcohol acyltransferase 2 (Awat2), has been established in our laboratory. Loss of Awat2 expression alters the composition and fluidity of the meibum consistent with EDED. The Awat2 KO mice were treated 1-2 times daily in both eyes with the rNPL593 (n=3) or vehicle control (n=2) starting at 2 months of age (initial onset of ocular surface disease). Slit lamp biomicroscopy, disease scoring and tear film diagnostics (phenol red thread test, fluorescein staining) were performed monthly for 1 year. After 1 year, animals were euthanized and eyes were processed for histopathology and von Kossa staining.

Results : At baseline, all animals exhibited marked meibomian gland dilation with white inspissated meibum, fibrillar material present in the tear film. At subsequent evaluations, progressive white corneal opacities were identified in the interpalpebral fissure of all animals; however, these opacities appeared earlier and were more pronounced and denser in the vehicle-treated animals. Additionally, the dilation of the meibomian glands in the rNPL593-treated animals was reduced over time. Histopathology identified subepithelial basophilic deposits in one vehicle-treated globe, consistent with mineral deposition.

Conclusions : These results demonstrate that treatment with the rNPL593 decreases clinical signs of EDED, possibly through alteration of the phase transition temperature of the abnormal meibum and/or diffusion into the meibomian gland. Future studies will be focused on determining (1) the mechanisms by which rNPL593 stabilizes the tear film lipid layer and (2) the clinical efficacy in larger cohorts of Awat2 KO mice, as well as canine models of spontaneous DED.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×